Editorial
Dear friends,
We begin this edition of our newsletter with a new article, written by the GMFH Editorial Board Coordinator, René van den Wijngaard, about the first study to clearly demonstrate the concept of keystone species in the context of reducing IBD risk through early-life interventions in genetically prone offspring.
Next up, Joël Doré and Andreu Prados highlight the most significant learnings from the 10th Gut Microbiota for Health World Summit, which took place on March 12 and 13 in Washington DC (USA), and how they might affect clinical practice in the foreseeable future.
You will also come across a new article that explores what we know so far about the role of the gut microbiota in diverticulitis and discusses two recent clinical trials on the role of probiotics in managing acute uncomplicated diverticulitis.
Finally, Prof. Ted Dinan from University College Cork (Ireland), met the GMFH team to talk about the evidence for the influence of the gut microbiota
on brain and behavior and potential gut microbiome-targeted interventions
that have benefits for mental health.
Happy reading!
The GMFH publishing team
|